Trait Biotech Corp., a Canadian biotech company developing cannabis-based pharmaceuticals, announced it has closed a C$31 million funding round, pushing total funding to date to C$70 million.

Canadian Cannabis Biotech Company Traits has raised C$31 million in its Series A financing round, as the company continues to advance its technological platform that can detect cannabis compounds in minute amounts.

Canadian Cannabis Biotech Company Trait Raises C$31 Million

Trait Biosciences Receives Strategic Investment From Btomorrow Ventures As Lead Investor In A C$31 Million Series A Financing

VANCOUVER, BC, June 16, 2021 /PRNewswire/ — Trait Biosciences Inc. (“Trait”) — a global leader in cannabinoid research focused on developing technologies that enable the production of safe, high-quality, predictable, and efficacious CBD products — today announced the completion of a C$31 million Series A financing round (the “Financing”). The Financing features a combination of new cash and the conversion of existing company debt. The Financing was led by Btomorrow Ventures (BTV), the corporate venturing unit of British American Tobacco (BAT), supported by Gotham Green Partners (GGP) and additional investors from Trait’s earlier fundraising rounds. The new funding will accelerate the research and development necessary to commercialize Trait’s proprietary 2XGLY Water Soluble Cannabinoid technology and enable Trait to underwrite R&D in an array of technologies designed to strengthen cannabinoid production practices and improve operating margins for cultivators. Trait is honored to work with BTV as a strategic investor to advance the commercialization of our unique IP portfolio, beginning with Trait’s proprietary water-soluble CBD extract that is superior to nano-emulsion.

Peter McDonough, Trait Biosciences CEO

Canadian Cannabis Biotech Company Trait Raises C$31 Million Trait’s groundbreaking innovation will be a catalyst for developing safer and higher quality CBD infused beverages and other consumer products. Trait currently has more than 90 active patent applications focused on innovative cannabinoid technology. Trait’s first-to-market product enabling readily available marketplace CBD extract to be converted into a superior, clear, tasteless, and fully water-soluble cannabinoid extract is slated to launch in 2022. The company is also developing a valuable IP portfolio in biomolecular plant transformation technology designed to significantly improve minor cannabinoid productivity in plants and strengthen overall crop yield for hemp cultivators. About Btomorrow Ventures (BTV) BTV is the corporate venturing unit of British American Tobacco (BAT). Established in 2020, BTV invests in high growth businesses, from seed funding to those looking for further, series B investment. BTV’s focus is to invest in world-class entrepreneurs with innovative products, and differentiating technologies. BTV supports BAT’s corporate purpose of building A Better Tomorrow™ and will accelerate its transformation into a multi-category consumer goods business. For more information visit our website: About Gotham Green Partners Gotham Green Partners (GGP) was founded in 2017 and formed upon the belief that the evolution of the CBD and cannabis markets will create a globally disruptive industry across medical, nutraceutical, and recreational use cases. At GGP we employ an opportunistic approach, investing in companies throughout every industry vertical, and target best-in-class operators with differentiated business models, defensible intellectual property, and scalable platforms. About Trait Biosciences Trait Biosciences Inc. is a global leader in cannabinoid research, focused on developing technologies that enable the production of safe, high-quality, low cost, predictable, and efficacious CBD products. Our mission is to develop the world’s most comprehensive integrated approach to cannabinoid science, insights, and technology. Original press release Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013. Canadian Cannabis Biotech Company Trait Raises C$31 Million Canadian Cannabis Biotech Company Trait Raises C$31 Million by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.


Privacy settings,How Search works,cbd stocks to watch

You May Also Like

Trulieve to Acquire Harvest Health for $2.1 Billion in Stock

Hey there! Before reading the article which is about Trulieve to Acquire…

Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie Award Winners in 2021 American Business Awards

On Tuesday, February 5, 2021, the Stevie Awards Foundation and the American…

HEXO to Acquire Redecan for $925 Million

Toronto-based licensed producer and cannabis conglomerate HEXO has agreed to acquire Toronto-based…

Greenlane Generates $34 Million Revenue in Q1

Greenlane Holdings, a major Canadian cannabis producer, reported this week that it…